This is what hugely derisks the company and the market misses it. Hoping people begin to appreciate the value of the past clinical trials and their relevance to the future.
Ann: Positive Pre-IND Guidance from FDA on Zantrene, page-5
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
-0.005(0.26%) |
Mkt cap ! $315.1M | |||
| Open | High | Low | Value | Volume |
| $1.95 | $1.95 | $1.84 | $288.9K | 153.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2000 | $1.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.93 | 1328 | 2 |
View Market Depth
| Last trade - 11.22am 15/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |